title: The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.
abstract: OBJECTIVE
  The American College of Rheumatology and the European League Against Rheumatism have developed new classification criteria for rheumatoid arthritis (RA). The aim of Phase 2 of the development process was to achieve expert consensus on the clinical and laboratory variables that should contribute to the final criteria set.
  
  
  METHODS
  Twenty-four expert RA clinicians (12 from Europe and 12 from North America) participated in Phase 2. A consensus-based decision analysis approach was used to identify factors (and their relative weights) that influence the probability of "developing RA," complemented by data from the Phase 1 study. Patient case scenarios were used to identify and reach consensus on factors important in determining the probability of RA development. Decision analytic software was used to derive the relative weights for each of the factors and their categories, using choice-based conjoint analysis.
  
  
  RESULTS
  The expert panel agreed that the new classification criteria should be applied to individuals with undifferentiated inflammatory arthritis in whom at least 1 joint is deemed by an expert assessor to be swollen, indicating definite synovitis. In this clinical setting, they identified 4 additional criteria as being important: number of joints involved and site of involvement, serologic abnormality, acute-phase response, and duration of symptoms in the involved joints. These criteria were consistent with those identified in the Phase 1 data-driven approach.
  
  
  CONCLUSIONS
  The consensus-based, decision analysis approach used in Phase 2 complemented the Phase 1 efforts. The 4 criteria and their relative weights form the basis of the final criteria set.
authors.affiliation: Boston University School of Medicine, Boston, Massachusetts, USA.
authors.forename: Tuhina
authors.initials: T
authors.lastname: Neogi
authors.forename: Daniel
authors.initials: D
authors.lastname: Aletaha
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Silman
authors.forename: Raymond L
authors.initials: RL
authors.lastname: Naden
authors.forename: David T
authors.initials: DT
authors.lastname: Felson
authors.forename: Rohit
authors.initials: R
authors.lastname: Aggarwal
authors.forename: Clifton O
authors.initials: CO
authors.lastname: Bingham
authors.forename: Neal S
authors.initials: NS
authors.lastname: Birnbaum
authors.forename: Gerd R
authors.initials: GR
authors.lastname: Burmester
authors.forename: Vivian P
authors.initials: VP
authors.lastname: Bykerk
authors.forename: Marc D
authors.initials: MD
authors.lastname: Cohen
authors.forename: Bernard
authors.initials: B
authors.lastname: Combe
authors.forename: Karen H
authors.initials: KH
authors.lastname: Costenbader
authors.forename: Maxime
authors.initials: M
authors.lastname: Dougados
authors.forename: Paul
authors.initials: P
authors.lastname: Emery
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Ferraccioli
authors.forename: Johanna M W
authors.initials: JM
authors.lastname: Hazes
authors.forename: Kathryn
authors.initials: K
authors.lastname: Hobbs
authors.forename: Tom W J
authors.initials: TW
authors.lastname: Huizinga
authors.forename: Arthur
authors.initials: A
authors.lastname: Kavanaugh
authors.forename: Jonathan
authors.initials: J
authors.lastname: Kay
authors.forename: Dinesh
authors.initials: D
authors.lastname: Khanna
authors.forename: Tore K
authors.initials: TK
authors.lastname: Kvien
authors.forename: Timothy
authors.initials: T
authors.lastname: Laing
authors.forename: Katherine
authors.initials: K
authors.lastname: Liao
authors.forename: Philip
authors.initials: P
authors.lastname: Mease
authors.forename: Henri A
authors.initials: HA
authors.lastname: Ménard
authors.forename: Larry W
authors.initials: LW
authors.lastname: Moreland
authors.forename: Raj
authors.initials: R
authors.lastname: Nair
authors.forename: Theodore
authors.initials: T
authors.lastname: Pincus
authors.forename: Sarah
authors.initials: S
authors.lastname: Ringold
authors.forename: Josef S
authors.initials: JS
authors.lastname: Smolen
authors.forename: Ewa
authors.initials: E
authors.lastname: Stanislawska-Biernat
authors.forename: Deborah
authors.initials: D
authors.lastname: Symmons
authors.forename: Paul P
authors.initials: PP
authors.lastname: Tak
authors.forename: Katherine S
authors.initials: KS
authors.lastname: Upchurch
authors.forename: Jirí
authors.initials: J
authors.lastname: Vencovský
authors.forename: Frederick
authors.initials: F
authors.lastname: Wolfe
authors.forename: Gillian
authors.initials: G
authors.lastname: Hawker
mesh_terms: D000210:Acute-Phase Reaction / Q000150:complications / Q000473:pathology; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000145:classification / Q000150:complications / Q000175:diagnosis*; D019963:Clinical Chemistry Tests; D032921:Consensus; D003658:Decision Making, Computer-Assisted; D003661:Decision Support Techniques; D005060:Europe; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007391:International Cooperation; D008297:Male; D009656:North America; D012219:Rheumatology / Q000379:methods*; D012955:Societies, Medical; D013585:Synovitis / Q000150:complications / Q000473:pathology; D009626:Terminology as Topic